Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy

Brain and Development

Volumn 30, Issue 6, 2008, Pages 430-433

  Chiyonobu, Tomohiro ^a   Noda, Rei ^a   Yoshida, Michiko ^a   Fujiki, Atsushi ^a   Ishii, Rumiko ^a   Nukina, Sadayuki ^a   Fujita, Kinya ^a   Goto, Yu ichi ^b   Morimoto, Masafumi ^c  

^a Akashi Municipal Hospital   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Intestinal pseudo obstruction; MELAS; Phenytoin

Indexed keywords

ADENINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; GUANINE; MITOCHONDRIAL DNA; NUCLEOTIDE; PHENOBARBITAL; PHENYTOIN; ZONISAMIDE;

ABDOMINAL DISTENSION; ADOLESCENT; APPETITE DISORDER; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONVALESCENCE; DNA DETERMINATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPTIC STATE; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITAL READMISSION; HUMAN; ILEUS; INTESTINE PSEUDOOBSTRUCTION; INTRACTABLE EPILEPSY; LOADING DRUG DOSE; MELAS SYNDROME; POINT MUTATION; SEIZURE; SYMPTOMATOLOGY; SYSTEMIC DISEASE; VOMITING;

ADOLESCENT; ANTICONVULSANTS; FEMALE; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; MAGNETIC RESONANCE IMAGING; MELAS SYNDROME; PHENYTOIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 42649117196     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2007.12.006     Document Type: Article

References (10)

1. Goto Y., Nonaka I., and Horai S. A mutation in the tRNA-Leu (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1990) 651-653
2. Hirano M., Silvestri G., Blake D.M., Lombes A., Minetti C., Bonilla E., et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44 (1994) 721-727
3. Nishino I., Spinazzola A., and Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283 (1999) 689-692
4. Krahenbuhl S., Brandner S., Kleinle S., Liechti S., and Straumann D. Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. Liver 20 (2000) 346-348
5. Shimotake T., Furukawa T., Inoue K., Iwai N., and Takeuchi Y. Familial occurrence of intestinal obstruction in children with the syndrome of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). J Pediatr Surg 33 (1998) 1837-1839
6. Mori O., Yamazaki M., Ohaki Y., Arai Y., Oguro T., Shimizu H., et al. Mitochondrial encephalomyopathy with lactic acidosis and stroke like episodes (MELAS) with prominent degeneration of the intestinal wall and cactus-like cerebellar pathology. Acta Neuropathol (Berl) 100 (2000) 712-717
7. Chang T.M., Chi C.S., Tsai C.R., Lee H.F., and Li M.C. Paralytic ileus in MELAS with phenotypic features of MNGIE. Pediatr Neurol 31 (2004) 374-377
8. Lyford G.L., and Farrugia G. Ion channels in gastrointestinal smooth muscle and interstitial cells of Cajal. Curr Opin Pharmacol 3 (2003) 583-587
9. Shafer R.B., Prentiss R.A., and Bond J.H. Gastrointestinal transit in thyroid disease. Gastroenterology 86 (1984) 852-855
10. Isojarvi J.I., Pakarinen A.J., and Myllyla V.V. Thyroid function with antiepileptic drugs. Epilepsia 33 (1992) 142-148